Atria Investments Inc Acquires 4,073 Shares of Cardinal Health, Inc. $CAH

Atria Investments Inc raised its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 17.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 27,709 shares of the company’s stock after buying an additional 4,073 shares during the quarter. Atria Investments Inc’s holdings in Cardinal Health were worth $4,349,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Integrated Wealth Concepts LLC grew its position in Cardinal Health by 6.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock worth $601,000 after purchasing an additional 280 shares during the last quarter. Jones Financial Companies Lllp grew its position in Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares in the last quarter. CWM LLC increased its stake in Cardinal Health by 6.3% during the second quarter. CWM LLC now owns 13,135 shares of the company’s stock valued at $2,207,000 after acquiring an additional 774 shares during the period. Moran Wealth Management LLC acquired a new position in Cardinal Health in the 2nd quarter valued at approximately $229,000. Finally, RFG Advisory LLC lifted its position in shares of Cardinal Health by 12.0% in the 2nd quarter. RFG Advisory LLC now owns 3,423 shares of the company’s stock worth $575,000 after acquiring an additional 368 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Up 2.6%

NYSE:CAH opened at $220.72 on Friday. The firm has a market cap of $51.94 billion, a PE ratio of 31.76, a price-to-earnings-growth ratio of 1.42 and a beta of 0.64. Cardinal Health, Inc. has a 12 month low of $120.72 and a 12 month high of $230.81. The company’s 50-day moving average price is $208.84 and its two-hundred day moving average price is $182.37.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, February 5th. The company reported $2.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.31 by $0.32. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The company had revenue of $65.63 billion during the quarter, compared to analysts’ expectations of $64.88 billion. During the same quarter in the previous year, the company posted $1.93 earnings per share. Cardinal Health’s quarterly revenue was up 18.8% compared to the same quarter last year. On average, research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be paid a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, April 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s payout ratio is currently 29.35%.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Recent quarterly results and underlying strength — Cardinal reported a Q4 EPS beat and revenue above expectations, with revenue up ~19% year-over-year, which analysts cite as supporting the stock’s upside. Cardinal Health’s (NYSE:CAH) Solid Earnings Are Supported By Other Strong Factors
• Positive Sentiment: Dividend confirmed — the Board approved a quarterly dividend of $0.5107 per share (payable Apr 15; record Apr 1). The cash return reinforces income appeal and signals confidence in cash flow. Cardinal Health Board of Directors Approves Quarterly Dividend
• Positive Sentiment: Analyst lift — JPMorgan raised its price target to $243, providing a tangible upside anchor for investors and helping sentiment. JPMorgan Chase Increases Cardinal Health Price Target
• Positive Sentiment: Zacks momentum & valuation coverage — CAH was added to Zacks’ Rank #1 momentum list and several Zacks pieces highlight undervaluation and a favorable long-term value case, which can attract momentum and value investors. Best Momentum Stock to Buy for February 13th Are Investors Undervaluing Cardinal Health?
• Neutral Sentiment: Kalkine notes logistics/reliability improvements on the NYSE composite — operational reliability updates are constructive but are incremental near-term drivers. Cardinal Health Boosts Logistics Reliability
• Neutral Sentiment: Analyst Q&A from the earnings call — the transcript highlights management’s priorities and risk items; useful for longer-term fundamental assessment but not an immediate catalyst. The 5 Most Interesting Analyst Questions From Cardinal Health’s Q4 Earnings Call

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Robert W. Baird set a $252.00 target price on Cardinal Health in a research note on Friday, February 6th. TD Cowen increased their price objective on shares of Cardinal Health from $233.00 to $251.00 and gave the company a “buy” rating in a research note on Wednesday. Citigroup upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and lifted their target price for the company from $190.00 to $244.00 in a research report on Friday, January 9th. Evercore ISI upped their target price on shares of Cardinal Health from $250.00 to $260.00 in a research note on Friday, February 6th. Finally, Argus raised their price target on shares of Cardinal Health from $232.00 to $248.00 and gave the stock a “buy” rating in a research note on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $245.19.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.